Petlife Pharmaceuticals Inc. (PTLF)

[02opida]

Pharmaceuticals, Inc. (OTCQB: PTLF) (the "Company"), a developer of a new generation of high- potency veterinary cancer medications and nutraceuticals for pets, through its subsidiary, PetLife Pharma International, Inc. (collectively "PetLife"), and in cooperation with Elite International Partners ("Elite"), announces its initiatives in Haiti to improve the lives of companion animals and the people of Haiti. With the cooperation and support of the Haitian government, and in partnership with the Mission Light of Light Church, PetLife is establishing a scorpion ranch and laboratory facilities ("PetLife Scorpion Ranch" ™), to harvest the venom of the Caribbean Blue Scorpion. This effort will provide the necessary material for PetLife's research efforts and production of its patent-pending formulation for the treatment of cancer in animals and humans.